1. Home
  2. FGEN vs NDLS Comparison

FGEN vs NDLS Comparison

Compare FGEN & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • NDLS
  • Stock Information
  • Founded
  • FGEN 1993
  • NDLS 1995
  • Country
  • FGEN United States
  • NDLS United States
  • Employees
  • FGEN N/A
  • NDLS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • FGEN Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • FGEN 33.5M
  • NDLS 32.9M
  • IPO Year
  • FGEN 2014
  • NDLS 2013
  • Fundamental
  • Price
  • FGEN $5.61
  • NDLS $0.73
  • Analyst Decision
  • FGEN Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • FGEN 1
  • NDLS 2
  • Target Price
  • FGEN $250.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • NDLS 206.5K
  • Earning Date
  • FGEN 08-05-2025
  • NDLS 08-06-2025
  • Dividend Yield
  • FGEN N/A
  • NDLS N/A
  • EPS Growth
  • FGEN N/A
  • NDLS N/A
  • EPS
  • FGEN N/A
  • NDLS N/A
  • Revenue
  • FGEN $6,996,000.00
  • NDLS $495,670,000.00
  • Revenue This Year
  • FGEN N/A
  • NDLS $5.37
  • Revenue Next Year
  • FGEN N/A
  • NDLS $0.68
  • P/E Ratio
  • FGEN N/A
  • NDLS N/A
  • Revenue Growth
  • FGEN N/A
  • NDLS N/A
  • 52 Week Low
  • FGEN $4.50
  • NDLS $0.55
  • 52 Week High
  • FGEN $38.25
  • NDLS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 39.07
  • NDLS 52.39
  • Support Level
  • FGEN $4.85
  • NDLS $0.66
  • Resistance Level
  • FGEN $5.77
  • NDLS $0.82
  • Average True Range (ATR)
  • FGEN 0.57
  • NDLS 0.07
  • MACD
  • FGEN -0.02
  • NDLS 0.00
  • Stochastic Oscillator
  • FGEN 31.67
  • NDLS 89.29

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: